Antidiabetic drug classes show varied associations with liver outcomes in T2DM, with SGLT2 inhibitors and GLP-1 RA ranking highest.
A class of diabetes drugs known as SGLT2 inhibitors may significantly reduce the risk of organ rejection in patients ...
A groundbreaking development in diabetes treatment reveals that SGLT-2 inhibitors significantly reduce dementia risk among type 2 diabetes patients. Recent research demonstrates these medications ...
Researchers developed a model using routine clinical data to identify optimal glucose-lowering therapies for patients with type 2 diabetes (T2D). Individuals receiving model-predicted optimal therapy ...
Some health-obsessed Americans believe the next antiaging therapeutic already exists—in the medicine cabinets of millions of diabetes patients. The widely used class of drugs, called SGLT2 inhibitors ...
A major new study reveals that older adults with cancer and type 2 diabetes who take GLP-1 receptor agonist medications (GLP-1RAs) experience significantly better overall survival rates compared to ...
LAKEWOOD, CO, UNITED STATES, April 27, 2026 /EINPresswire.com/ -- The American Animal Hospital Association (AAHA) today ...
Everyday Health on MSN
A guide to medications for type 2 diabetes and chronic kidney disease
Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Nearly 17 million young Americans could be eligible for GLP-1RAs—a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results